Fruitive Offers Healthy Plant-Based Food Franchise Opportunities Across USA

Fruitive has announced that the company is now offering healthy, plant-based casual food franchise opportunities across the USA. The company was founded in Virginia Beach in 20111 and since then, the company has witnessed a tremendous expansion from its previous Hilltop location to two new locations in Virginia and Norfolk. The casual food eatery also focused on markets of the local farmers across Washington, D.C.

Chief Executive Officer and Founder of Fruitive, Gregg Rozeboom said, “My goal with Fruitive was to create something good for my family, for our community and for the world.”

“The market for plant-based, healthy foods has continued to grow at an unprecedented rate, and I knew there was an opportunity here. When I decided to start the company, I traveled to vegan restaurants around the nation to see what was working and what wasn’t, and I’m confident we’ve created a brand that will provide a rewarding investment to franchise owners,” Rozeboom further added.

“As we open our brand up to a new wave of restaurateurs, we really want franchisees who are excited about promoting health and wellness,” Rozeboom added.

“At Fruitive, we offer an extensive training program that covers everything from finance and real estate to sales and marketing. We want to empower our franchisees with an opportunity to invest in both themselves and the planet, and we’re looking forward to seeing Fruitive locations across the nation,” Rozeboom concluded.

The founder of the company Gregg Rozeboom wanted to open a restaurant that prized kindness and authenticity above all. The eatery has combined various health concepts in its menu from bananas on toasted-whole grain bread to almond butter with cacao nibs and chocolate drizzle topped with the delicious and mouth-watering coconut cream and served with the maple syrup and lavender.

TWN Communications Officially Introduced TWN Professional Services Group To Drive Broadband Offering

TWN Communication has announced that the company has officially introduced the TWN Professional Services Group to drive Broadband offering. The broadband service provider will assist in installing the TWN communication for rural electric cooperatives.

The company has got the collectible 300 years of experience in areas of public policy advocacy, state communications law, regulations, broadband provider and advanced technology for business operations. The company has also partnered with the well-seasoned industry experts to facilitate their transition into broadband services.

TWN is a leading United States based Broadband Service Provider company.

The company has got years of valuable experience in installing and managing broadband services. The company engages different industries with on-call advice, focused subject matter as well as customer engagements to release and issue white papers and advisories.

Chief Financial Officer of Mohave Electric Cooperative in Arizona, Ardie Lauxman said, “Having a resource to call upon is crucial for co-ops trying to navigate the complex world of broadband deployment. TWN Professional Services has helped us every step of the way with our state and federal funding applications. The team’s expertise and depth of knowledge with the legal, technical and financial aspects of these applications and their ability to coordinate all of these aspects together have made the application processes as seamless as possible.”

“Rural electric cooperatives seek to bring critical broadband services to their membership without exposing the co-op to significant financial risk. State and federal legislatures and regulatory authorities are actively pursuing, and eager to support, low-risk solutions to the rural digital divide dilemma. TWN-PS experts are well-equipped to identify, explain and assist in developing strategies and making use of governmental assistance programs to achieve these common goals.”

Notable News to Watch: NuVasive (NASDAQ:NUVA)

NuVasive (NASDAQ:NUVA) spotted trading -30.64% off 52-week high price. On the other end, the stock has been noted 98.98% away from the low price over the last 52-weeks. The stock changed -2.84% to recent value of $56.81. The stock transacted 1089592 shares during most recent day however it has an average volume of 1.14M shares. The company has 53.22M of outstanding shares and 49.83M shares were floated in the market.

On May 06, 2020, NuVasive (NASDAQ:NUVA) the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, released financial results for the quarter ended March 31, 2020.

First Quarter 2020 Highlights

  • Revenue decreased -5.4% to $259.9 million, or -5.1% on a constant currency basis;
  • GAAP operating margin of 10.9%; Non-GAAP operating margin of 16.9%; and
  • GAAP diluted earnings per share of $0.10; Non-GAAP diluted earnings per share of $0.48.

First and foremost, I want to recognize the healthcare professionals who are battling COVID-19 on the front lines and whose work is truly heroic during this global healthcare crisis, said J. Christopher Barry, chief executive officer of NuVasive. Additionally, I am proud of the resiliency demonstrated by NuVasive employees, as the Company remains committed to supporting our surgeon partners and their patients during this time.

NuVasive’s first quarter performance was consistent with the preliminary revenue results provided in the business update shared last month, Barry continued. The Company began the quarter positioned to build upon the financial momentum delivered last year, but faced a decline in elective procedure volumes due to the COVID-19 pandemic. However, with a strong cash position, dedicated team and innovative technology in our pipeline, we are confident in the long-term trajectory of the business and our purpose to transform surgery, advance care and change lives. Its earnings per share (EPS) expected to touch remained 414.80% for this year while earning per share for the next 5-years is expected to reach at 9.63%. NUVA has a gross margin of 73.30% and an operating margin of 10.50% while its profit margin remained 5.60% for the last 12 months.

According to the most recent quarter its current ratio was 3.7 that represents company’s ability to meet its current financial obligations. The price moved ahead of -0.59% from the mean of 20 days, 6.28% from mean of 50 days SMA and performed -13.92% from mean of 200 days price. Company’s performance for the week was -1.03%, 34.38% for month and YTD performance remained -24.40%.

Stock News Update: Enbridge Inc. (NYSE:ENB)

Enbridge Inc. (NYSE:ENB) stock observed trading -30.22% off 52-week high price. On the other end, the stock has been noted 33.41% away from low price over the last 52-weeks. The stock disclosed a move of -2.25% away from 50 day moving average and -15.22% away from 200 day moving average. Moving closer, we can see that shares have been trading 3.28% off 20-day moving average. It has market cap of $62.46B and dividend yield of 7.97%.

On May 04, 2020, Enbridge Inc. (NYSE:ENB) reported that it does not intend to exercise its right to redeem its currently outstanding Cumulative Redeemable Preference Shares, Series 13 (Series 13 Shares) (TSX: ENB.PF.E) on June 1, 2020. As a result, subject to certain conditions, the holders of the Series 13 Shares have the right to convert all or part of their Series 13 Shares on a one-for-one basis into Cumulative Redeemable Preference Shares, Series 14 of Enbridge (Series 14 Shares) on June 1, 2020. Holders who do not exercise their right to convert their Series 13 Shares into Series 14 Shares will retain their Series 13 Shares.

The foregoing conversion right is subject to the conditions that: (i) if Enbridge determines that there would be less than 1,000,000 Series 13 Shares outstanding after June 1, 2020, then all remaining Series 13 Shares will automatically be converted into Series 14 Shares on a one-for-one basis on June 1, 2020; and (ii) alternatively, if Enbridge determines that there would be less than 1,000,000 Series 14 Shares outstanding after June 1, 2020, no Series 13 Shares will be converted into Series 14 Shares. There are currently 14,000,000 Series 13 Shares outstanding.

With respect to any Series 13 Shares that remain outstanding after June 1, 2020, holders thereof will be entitled to receive quarterly fixed cumulative preferential cash dividends, as and when declared by the Board of Directors of Enbridge. The new annual dividend rate applicable to the Series 13 Shares for the five-year period commencing on June 1, 2020 to, but excluding, June 1, 2025 will be 3.043 percent, being equal to the five-year Government of Canada bond yield of 0.383 percent determined as of  plus 2.66 percent in accordance with the terms of the Series 13 Shares.

The Canada based company Enbridge Inc. moved with change of 0.84% to $30.11 with the total traded volume of 3743079 shares in recent session versus to an average volume of 6.52M. The stock was observed in the 5 days activity at 1.52%. The one month performance of stock was 9.53%. ENB’s shares are at -26.69% for the quarter and driving a -17.84% return over the course of the past year and is now at -24.29% since this point in 2018.  Right now the stock beta is 0.84. The average volatility for the week and month was at 3.20% and 3.08% respectively. There are 2.07B shares outstanding and 2.02B shares are floated in market.

Notable News to Watch: CSI Compressco LP (NASDAQ:CCLP)

CSI Compressco LP (NASDAQ:CCLP) spotted trading -88.19% off 52-week high price. On the other end, the stock has been noted 34.84% away from the low price over the last 52-weeks. The stock changed -6.00% to recent value of $0.47. The stock transacted 572447 shares during most recent day however it has an average volume of 286.26K shares. The company has 52.60M of outstanding shares and 46.07M shares were floated in the market.

On May 04, 2020, CSI Compressco LP (NASDAQ:CCLP) declared first quarter 2020 results.

CSI Compressco’s consolidated revenues for the quarter ended March 31, 2020 were $90 million, down 27% from the fourth quarter of 2019 due to lower equipment sales and weaker aftermarket services activity. Compression services revenue increased sequentially by 1% on the addition to the fleet of 22,160 horsepower of new equipment.  Compared to the first quarter of 2019, revenue was down 13% also due to lower equipment sales.

Net loss for the quarter ended March 31, 2020 was $13.6 million compared to a net loss of $2.0 million in the fourth quarter of 2019 and a net loss of $12.5 million for the first quarter of 2019. Net loss per diluted common unit for first quarter 2020 was $0.28 as compared to a net loss per diluted common unit of $0.04 in the fourth quarter of 2019 and a net loss per diluted common unit of $0.26 in the first quarter of 2019.

Net loss in the first quarter of 2020 included $6.0 million of unusual items, primarily related to impairment of long-lived assets and inventory related to the planned closure of our Midland fabrication facility. First quarter Adjusted EBITDA was $27.8 million, down $6.9 million from the fourth quarter 2019 due to weaker aftermarket services activity and lower equipment sales.

Its earnings per share (EPS) expected to touch remained 49.80% for this year while earning per share for the next 5-years is expected to reach at 3.70%. CCLP has a gross margin of 33.40% and an operating margin of 7.80% while its profit margin remained -4.30% for the last 12 months.

According to the most recent quarter its current ratio was 1.2 that represents company’s ability to meet its current financial obligations. The price moved ahead of -18.05% from the mean of 20 days, -47.53% from mean of 50 days SMA and performed -79.24% from mean of 200 days price. Company’s performance for the week was 8.72%, -24.20% for month and YTD performance remained -82.69%.

Pressure Biosciences Announces A Letter Of Intent To Purchase SkinScience Labs

Pressure Biosciences, a leader of pressure-based instruments, cosmeceuticals, biotherapeutics, biotechnology, food & beverage, has made on Thursday April 30, 2020 that the announcement of letter to acquire the SkinScience Labs, Inc, which is a parent company of Dr. Denese Anti-Aging and skin care product lines.

According to the details released by the PR Newswire News Agency, the company has also announced the plans to acquire Cannaworx on April 28, 2020. Dr. Denese is an global leader in scientific skin care remedies through technologies. Dr. Denese has also created the award winning Dr. Denese SkinScience. All the skin line, skin care and aging products of Dr. Denese have been the top seller over the past 17 years.

Chief Executive Officer and President PBI, Mr. Richard Schumacher said, “The Dr. Denese SkinScience brand has reached the top performing status on QVC for a skin care line, selling over 25 million units and receiving multiple QVC customer choice beauty awards.”

“Adrienne’s tremendous brand recognition, regularly repeating customer base, and major existing sales momentum brings immediate accretive impact into the PBI portfolio – and we know that our UST nanoemulsions will create powerful new leverage and opportunities for her expanding product lines. Our team has worked very hard to bring this pivotal transition together for PBI and its shareholders, and we are very excited about the prospects for growth and value appreciation in our combined companies going forward,” Mr. Schumacher further added.

Partner of Dr. Denese to Create Cannaworx, Dr. Bobby Ghalil said, “We are very proud to have a luminary like Dr. Denese bringing her vision and dedication to breakthrough innovations and quality in skin care and anti-aging products, and her large and loyal following of dedicated customers into our new, combined company.”

Watch List Stock News: Allegiance Bancshares (NASDAQ:ABTX)

Allegiance Bancshares (NASDAQ:ABTX) is now trading -41.77% off 52-week high price. On the other end, the stock has been noted 8.62% away from the low price over the last 52-weeks. The stock changed 1.02% to recent value of $22.68. The stock transacted 53787 shares during most recent day however it has an average volume of 113.20K shares. The company has 21.38M of outstanding shares and 18.67M shares were floated in the market.

On April 24, 2020, Allegiance Bancshares (NASDAQ:ABTX) the holding company of Allegiance Bank, declared the addition of Ms. Denise Castillo-Rhodes and Ms. Janet S. Wong to Allegiance’s Board of Directors. I am very pleased that Ms. Castillo-Rhodes and Ms. Wong have agreed to join our Board, said George Martinez, Chairman of Allegiance.

Ms. Castillo-Rhodes is currently the Executive Vice President and Chief Financial Officer of Texas Medical Center, where she oversees accounting, finance, billing and collections and tax compliance. Ms. Castillo-Rhodes is a certified public accountant and a member of the American Institute of Certified Accountants, the Texas Society of Certified Public Accountants and the Houston Chapter of Certified Public Accountants. Ms. Castillo-Rhodes’ professional experience as a financial executive and other leadership experience qualify her to provide pertinent guidance to Allegiance’s board, as well as the Audit Committee.

Ms. Wong is a licensed Certified Public Accountant and has more than 30 years of public accounting experience. She is a retired partner with KPMG, an international professional services firm, where she has extensive industry experience in technology, manufacturing, financial services and consumer products. Since 2013, Ms. Wong has served as a National Executive Advisor for Ascend, a nonprofit professional organization that enables its members, corporate partners and the community to realize the leadership potential of Asians in global corporations, where she leads the largest network of Asian corporate board directors serving U.S. boards and facilitates leadership programs to Fortune 500 and professional services companies throughout the U.S. In 2015, she was elected to the Board of Directors of Enviva Partners (NYSE: EVA) and also serves as their Audit Committee Chair. Ms. Wong’s audit expertise and her professional and leadership experience qualify her to serve on Allegiance’s board, as well as on the Audit and Corporate Governance and Nominating Committees.

Its earnings per share (EPS) expected to touch remained 4.50% for this year.

The price moved ahead of -3.17% from the mean of 20 days, -19.27% from mean of 50 days SMA and performed -31.55% from mean of 200 days price. Company’s performance for the week was -2.03%, -5.62% for month and YTD performance remained -39.68%.

News Recap: Portland General Electric Company (NYSE:POR)

Portland General Electric Company (NYSE:POR) stock identified change of 22.68% away from 52-week low price and recently located move of -26.43% off 52-week high price. It has market worth of $4.15B and dividend yield of 3.32%. POR stock has been recorded -11.37% away from 50 day moving average and -16.18% away from 200 day moving average. Moving closer, we can see that shares have been trading -5.87% off 20-day moving average.

On April 24, 2020, Portland General Electric Company (NYSE:POR) released net income of $81 million, or 91 cents per diluted share, for the first quarter of 2020. This compares with net income of $73 million, or 82 cents per diluted share, for the first quarter of 2019.

Our financial performance this quarter largely reflects conditions experienced prior to the COVID-19 pandemic, said Maria Pope, PGE president and CEO. PGE is committed to serving the needs of our customers and our community during this time. Given the deteriorating economic outlook, the company is revising full-year earnings guidance to $2.20 to $2.50 per diluted share. This guidance includes a decrease in annual retail deliveries of 1 to 2%, weather-adjusted, and reflects management actions to reduce operating and maintenance and capital spending. Our forecasts of long-term earnings growth remain at 4 to 6%.

First quarter 2020 earnings compared to first quarter 2019 earnings

Total revenues showed no change as increases in retail revenues and wholesale revenues were offset by a decrease in other operating revenues. Lower purchased power and fuel expense resulted from a lower power cost per MWh, primarily due to strong wind production. In addition, lower operating expenses were driven by reduced plant maintenance expense, which was partially offset by increased distribution expense. Earnings were also impacted by a decline in the market value of the non-qualified benefit trust and higher depreciation and amortization as the result of capital additions.

The Utilities sector company, Portland General Electric Company noticed change of -4.17% to $46.41 along volume of 1433680 shares in recent session compared to an average volume of 871.74K. The stock observed return of -8.68% in 5 days trading activity. The stock was at 6.30% over one month performance. POR’s shares are at -23.10% for the quarter and driving a -9.85% return over the course of the past year and is now at -16.81% since this point in 2018.

The average volatility for the week at 4.32% and for month was at 5.41%. There are 89.37M shares outstanding and 89.08M shares are floated in market. Right now the stock beta is 0.43.

Keep Your Eyes on Stock News: Kentucky First Federal Bancorp (NASDAQ:KFFB)

Kentucky First Federal Bancorp (NASDAQ:KFFB) noted trading -29.87% off 52-week high price. On the other end, the stock has been noted 31.82% away from the low price over the last 52-weeks. The stock changed 5.45% to recent value of $5.8. The stock transacted 11144 shares during most recent day however it has an average volume of 4.19K shares. The company has 8.10M of outstanding shares and 3.14M shares were floated in the market.

On April 17, 2020, Kentucky First Federal Bancorp (NASDAQ:KFFB) the holding company for First Federal Savings and Loan Association of Hazard, Kentucky and First Federal Savings Bank of Kentucky, Frankfort, Kentucky, released that the Company’s Board of Directors declared a cash dividend of $0.10 per share payable on May 18, 2020, to shareholders of record on April 30, 2020.  Tony Whitaker, Chairman of the Company, stated that the Board of Directors determined that the payment of the dividend was appropriate in light of the Company’s capital position and financial condition.

This press release may contain statements that are forward-looking, as that term is defined by the Private Securities Litigation Act of 1995 or the Securities and Exchange Commission in its rules, regulations and releases. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. All forward-looking statements are based on current expectations regarding important risk factors including, but not limited to, real estate values, the impact of interest rates on financing, changes in general economic conditions, legislative and regulatory changes that adversely affect the business of the Company and the ability of First Federal MHC to waive dividends and changes in the securities markets. Accordingly, actual results may differ from those expressed in the forward-looking statements, and the making of such statements should not be regarded as a representation by the Company or any other person that results expressed therein will be achieved.

Kentucky First Federal Bancorp is the parent company of First Federal Savings and Loan Association, which operates one banking office in Hazard, Kentucky and First Federal Savings Bank of Kentucky, which operates six banking offices in Kentucky, including three in Frankfort, two in Danville, and one in Lancaster. Kentucky First Federal Bancorp shares are traded on the NASDAQ National Market under the symbol KFFB. At March 31, 2020, the Company had approximately 8,262,215 shares outstanding of which approximately 57.22% was held by First Federal MHC.

Its earnings per share (EPS) expected to touch remained -22.80% for this year.

The price moved ahead of 2.08% from the mean of 20 days, -14.63% from mean of 50 days SMA and performed -21.65% from mean of 200 days price. Company’s performance for the week was 0.37%, -12.37% for month and YTD performance remained -25.16%.

Stock News Alert: Crinetics Pharmaceuticals (NASDAQ:CRNX)

Crinetics Pharmaceuticals (NASDAQ:CRNX) moved -0.84% to recent value of $15.35. The stock transacted 234406 shares during most recent day however it has an average volume of 100.12K shares. It spotted trading -46.71% off 52-week high price. On the other end, the stock has been noted 44.40% away from the low price over the last 52-weeks.

On April 17, 2020, Crinetics Pharmaceuticals (NASDAQ:CRNX) a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, notified that it has closed its previously announced underwritten public offering of 8,222,500 shares of its common stock, including 1,072,500 shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, at a price to the public of $14.00 per share. The gross proceeds to Crinetics from the offering, before deducting the underwriting discounts and commissions and other offering expenses, were approximately $115.1 million.

Crinetics intends to use the net proceeds from the offering to fund the development of paltusotine and its other research and development programs, and for working capital and general corporate purposes.

Its earnings per share (EPS) expected to touch remained -86.10% for this year.  The company has 23.32M of outstanding shares and 20.61M shares were floated in the market. According to the most recent quarter its current ratio was 14.8 that represents company’s ability to meet its current financial obligations. The price moved ahead of 8.17% from the mean of 20 days, -12.39% from mean of 50 days SMA and performed -20.54% from mean of 200 days price. Company’s performance for the week was 11.23%, 32.67% for month and YTD performance remained -38.82%.